- Inhibition of Human Pancreatic Tumor Growth by Cytokine-Induced Killer Cells in Nude Mouse Xenograft Model
-
Kim JS, Park YS, Kim JY, Kim YG, Kim YJ, Lee HK, Kim HS, Hong JT, Kim Y, Han SB
- KMID: 2150756
- Immune Netw.
- 2012 Dec;12(6):247-252.
- doi: 10.4110/in.2012.12.6.247
Pancreatic cancer is the fourth commonest cause of cancer-related deaths in the world. However, no adequate therapy for pancreatic cancer has yet been found. In this study, the antitumor activity... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Adjuvant Immunotherapy with Cytokine-Induced Killer Cells for Relapsed or Refractory Neuroblastoma
-
Choi JY, An HY, Hong KT, Hong C, Kang HJ, Shin HY
- KMID: 2435416
- Clin Pediatr Hematol Oncol.
- 2018 Oct;25(2):202-207.
- doi: 10.15264/cpho.2018.25.2.202
The treatment outcomes of relapsed or refractory neuroblastoma have been unsatisfactory till date. We reported two cases of adoptive immunotherapy using cytokine-induced killer (CIK) cells against relapsed or refractory neuroblastoma.... -
- CITED
-
- Close
- SHARE
-
- Close
- Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
-
Kim JS, Kim YG, Pyo M, Lee HK, Hong JT, Kim Y, Han SB
- KMID: 2168030
- Immune Netw.
- 2015 Apr;15(2):58-65.
- doi: 10.4110/in.2015.15.2.58
Melanoma is the most aggressive skin cancer and its incidence is gradually increasing worldwide. Patients with metastatic melanoma have a very poor prognosis (estimated 5-year survival rate of -
- CITED
-
- Close
- SHARE
-
- Close
- Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells
-
Kim JS, Kim YG, Park EJ, Kim B, Lee HK, Hong JT, Kim Y, Han SB
- KMID: 2168050
- Immune Netw.
- 2016 Apr;16(2):99-108.
- doi: 10.4110/in.2016.16.2.99
Colorectal cancer is the third leading cancer worldwide. Although incidence and mortality of colorectal cancer are gradually decreasing in the US, patients with metastatic colorectal cancer have poor prognosis with... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Management for Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis by Autologous Natural Killer Cells Combined with Immune Checkpoint Inhibitor
-
Woo A, Kim EJ, Shin SY, Jeon HJ, Park H, Chon YE, Lee YB, Hwang SG, Rim KS, Lee JH
- KMID: 2409651
- J Liver Cancer.
- 2018 Mar;18(1):67-74.
- doi: 10.17998/jlc.18.1.67
Hepatocellular carcinoma (HCC) has extremely poor prognosis. Immunotherapy has emerged as a new treatment for a number of cancers. Adoptive immunotherapy is one of the important cancer immunotherapy, which relies... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances and Future Directions in Immunotherapeutics for Hepatocellular Carcinoma
-
Cho Y, Han J, Kim W
- KMID: 2448271
- J Liver Cancer.
- 2019 Mar;19(1):1-11.
- doi: 10.17998/jlc.19.1.1
Systemic target therapeutic drugs, such as sorafenib, lenvatinib, or regorafenib are the only drugs that are known to be effective against advanced hepatocellular carcinoma (HCC). However, these agents show a... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer
-
Li M, Wang Y, Wei F, An X, Zhang N, Cao S, Ren B, Zhang X, Ren X
- KMID: 2413933
- J Breast Cancer.
- 2018 Jun;21(2):150-157.
- doi: 10.4048/jbc.2018.21.2.150
PURPOSE: The treatment of triple-negative breast cancer (TNBC) remains challenging, due to the absence of estrogen, progesterone, and human epidermal growth factor receptors. This study was designed to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Early Recurred Hepatocellular Carcinoma after Surgical Resection Which Showed Different Outcomes
-
Cho YY, Lee JH, Yi NJ, Lee KW, Suh KS, Kim YJ, Yoon JH
- KMID: 2198544
- J Liver Cancer.
- 2015 Sep;15(2):126-131.
- doi: 10.0000/jlc.2015.15.2.126
Hepatocellular carcinoma (HCC) has poor prognosis, even after curative resection. Early recurrence after curative treatment is a major cause of the poor prognosis. Pathologic factors such as vessel invasion, satellite... -
- CITED
-
- Close
- SHARE
-
- Close
